{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20221006",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "72270",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/214103Orig1s003ltr.pdf",
              "date": "20221007",
              "type": "Letter"
            },
            {
              "id": "72281",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214103s003lbl.pdf",
              "date": "20221011",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20201123",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "65349",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/214103Orig1s000ltr.pdf",
              "date": "20201125",
              "type": "Letter"
            },
            {
              "id": "65531",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214103lbl.pdf",
              "date": "20201208",
              "type": "Label"
            },
            {
              "id": "65662",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/214103Orig1s000TOC.html",
              "date": "20201221",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20250404",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "81832",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214103s006lbl.pdf",
              "date": "20250407",
              "type": "Label"
            },
            {
              "id": "81886",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/214103Orig1s006ltr.pdf",
              "date": "20250408",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20230919",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "75521",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/214103Orig1s004ltr.pdf",
              "date": "20230920",
              "type": "Letter"
            },
            {
              "id": "75527",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214103s004lbl.pdf",
              "date": "20230921",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA214103",
      "sponsor_name": "ALNYLAM PHARMS INC",
      "openfda": {
        "application_number": [
          "NDA214103"
        ],
        "brand_name": [
          "OXLUMO"
        ],
        "generic_name": [
          "LUMASIRAN"
        ],
        "manufacturer_name": [
          "Alnylam Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "71336-1002"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "LUMASIRAN SODIUM"
        ],
        "rxcui": [
          "2467153",
          "2467158"
        ],
        "spl_id": [
          "6ef869cb-8ccd-4339-9991-0fab45da1fbd"
        ],
        "spl_set_id": [
          "16985a31-f5e4-4557-9266-fc78d4bc5055"
        ],
        "package_ndc": [
          "71336-1002-1"
        ],
        "unii": [
          "67P6XH37HD"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "OXLUMO",
          "active_ingredients": [
            {
              "name": "LUMASIRAN SODIUM",
              "strength": "EQ 94.5MG BASE/0.5ML (EQ 94.5MG BASE/0.5ML)"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "SOLUTION",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}